AstraZeneca (AZNCF) News Today $142.40 -3.08 (-2.11%) As of 02/21/2025 03:44 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period AstraZeneca receives A1 rating upgrade from Moody's, outlook stableFebruary 21 at 6:59 PM | investing.comFibroGen sells China unit to AstraZeneca for $160mFebruary 20 at 7:05 PM | finance.yahoo.comAstraZeneca boosts China presence with FibroGen's anemia drug in $160 million dealFebruary 20 at 2:04 PM | msn.comAmid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 MillionFebruary 20 at 2:04 PM | benzinga.comFDA posts observations from AstraZeneca site inspectionFebruary 20 at 2:04 PM | markets.businessinsider.comBernstein Reaffirms Their Buy Rating on AstraZeneca (AZN)February 20 at 9:02 AM | markets.businessinsider.comAstraZeneca to buy FibroGen's China unit for $160 millionFebruary 20 at 9:02 AM | msn.comAstraZeneca hit with US class action lawsuit over China regulatory probesFebruary 18, 2025 | ft.comAstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 7.2% in JanuaryFebruary 18, 2025 | americanbankingnews.comAstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trialFebruary 17, 2025 | msn.comAstraZeneca: IMFINZI improved event-free survival, OS across MIBCFebruary 15, 2025 | markets.businessinsider.comAstraZeneca upgraded to Buy from Neutral at UBSFebruary 13, 2025 | markets.businessinsider.comAstraZeneca upgraded by UBS to buy on growth potentialFebruary 13, 2025 | msn.comBofA maintains Buy on AstraZeneca stock, GBP145.00 targetFebruary 12, 2025 | msn.comAstraZeneca's Future Dividend Projections Appear Well Covered By EarningsFebruary 9, 2025 | finance.yahoo.comInside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapseFebruary 7, 2025 | msn.comAstraZeneca (AZN) Receives a Hold from DZ BANK AGFebruary 7, 2025 | markets.businessinsider.comAstraZeneca (AZN) Gets a Hold from Deutsche BankFebruary 7, 2025 | markets.businessinsider.comAstraZeneca PLC (NASDAQ:AZN) Q4 2024 Earnings Call TranscriptFebruary 7, 2025 | msn.comAstraZeneca reports Q4 core EPS $2.09, up 49% at CERFebruary 6, 2025 | markets.businessinsider.comAstraZeneca CEO says company has no access to executive Wang, in detention in ChinaFebruary 6, 2025 | reuters.comAstraZeneca Boss Says UK ‘Isn’t the Worst Place’ to InvestFebruary 6, 2025 | msn.comAstraZeneca gains as Q4 results clear China overhangFebruary 6, 2025 | msn.com4AZN : AstraZeneca Unusual Options ActivityFebruary 6, 2025 | benzinga.comAstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.February 6, 2025 | msn.comAstraZeneca Sales and Profit Outshine Estimates on Cancer DrugsFebruary 6, 2025 | bloomberg.comAstraZeneca shares rise as China probe update reassuresFebruary 6, 2025 | msn.comDrugmaker AstraZeneca flags possible $4.5 million Chinese tax fineFebruary 6, 2025 | msn.comAstraZeneca Sales, Core EPS Seen Rising -- Earnings PreviewFebruary 5, 2025 | marketwatch.comAstraZeneca lung cancer therapy Imfinzi recommended for EU approvalFebruary 4, 2025 | msn.comAstraZeneca’s Imfinzi recommended for approval in EU by CHMPFebruary 3, 2025 | markets.businessinsider.comAstraZeneca investment deal ‘didn’t add up for UK taxpayer’, says ministerFebruary 3, 2025 | msn.comAstraZeneca offered 'significant' sum, says ministerFebruary 3, 2025 | msn.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZenecaFebruary 3, 2025 | markets.businessinsider.comAstraZeneca's Imfinzi endorsed for EU approval for lung cancer careFebruary 3, 2025 | lse.co.ukAstraZeneca Stock Rally Will be Tested by Answers on China ProbeFebruary 3, 2025 | bloomberg.comAstraZeneca cancels £450m investment in UK after dispute over Government supportFebruary 2, 2025 | msn.comMayor wants to continue talks with AstraZenecaFebruary 2, 2025 | msn.com'AstraZeneca ditches vaccine plant' and Trump's EU tariff threatFebruary 1, 2025 | yahoo.comAstraZeneca Scraps Plan To Expand Vaccine Plant In UK In Blow To GovernmentJanuary 31, 2025 | msn.comAstraZeneca Calls Off Vaccine Hub Investment Over UK FundingJanuary 31, 2025 | bloomberg.comAstraZeneca scraps plan to expand vaccine plant in the UK in blow to governmentJanuary 31, 2025 | msn.comAstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth planJanuary 31, 2025 | msn.comAstraZeneca's SWOT analysis: pharma giant's stock poised for growth amid challengesJanuary 30, 2025 | msn.comAstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in USJanuary 28, 2025 | lse.co.ukAstraZeneca's Enhertu gets additional FDA approvalJanuary 27, 2025 | msn.comAstraZeneca to Invest C$820 Million to Move to Larger Toronto OfficeJanuary 25, 2025 | marketwatch.comAstraZeneca expands global R&D hub in Ontario, CanadaJanuary 25, 2025 | markets.businessinsider.comAstraZeneca to invest $570m in Canada, creating 700 new jobsJanuary 24, 2025 | msn.comAstraZeneca To Pump $570 Million Into Canada, Driving Expansion, Job GrowthJanuary 24, 2025 | benzinga.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address AZNCF Media Mentions By Week AZNCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZNCF News Sentiment▼0.020.60▲Average Medical News Sentiment AZNCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZNCF Articles This Week▼107▲AZNCF Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Anew Medical News Today Arno Therapeutics News Today AVAX Technologies News Today AVVAA World Health Care Products News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AZNCF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts